Neurospine Search



  • HOME
  • Sponsor

Platinum Level Gold Level Silver Level Bronze Level

• Neurospine expresses sincere gratitude to our proud corporate supporters.
• Neurospine and Corporate sponsors should follow regulation of Fair Trade Act of Korea.
• Editorial and review activities of Neurospine are strictly independent from corporate supporters.
• Neurospine staff would be happy to discuss with potential corporate supporters in additional partnership prospects.

Please contact:
        Mrs. Gye Soon Ahn
        Department of Neurosurgery, Yonsei University College of Medicine.
        50-1, Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
        Tel: +82-2-2228-2158

Platinum Sponsors

CG Bio

CG Bio is a total healthcare provider with a goal of enhancing the quality of life by offering range of innovative solutions for the spectrum of spinal disorders. Through extensive research activity, CG Bio is a leading comprehensive portfolio of allograft and synthetic bone grafts, spinal implants, and Growth Factor rh-BMP2. Cell & Growth Factor Biotechnology.


Gold Sponsors


Powered by our portfolio of Advanced Surgery products:
    The haemostats trusted to stop the bleeding.
    The sealants clinicians count on to close the wounds.
    The tissue and bone repair solutions surgeons rely on to promote healing.

Because they have confidence that these products will work. With Baxter’s advanced surgery solutions, it’s the details that make a big difference. Driving clinician confidence. Reducing the time patients spend in the OR. Creating efficiencies. Impacting clinical outcomes – and real lives. Across specialties. Throughout health systems. Around the globe. Merging art and science, Together with our clinical partners, we embody hope and empower healing.
Baxter. Advanced Surgery Advancing the art of healing.


Since its establishment in 1997, Cellumed Co.,Ltd is a bio company that manufactures and supplies medical devices, biologics, and cosmeceuticals under the corporate philosophy of respecting human beings.

We succeeded in developing and mass-producing animal(CHO cell)-derived bone formation protein rhBMP2 for the first time in Asia and the second in the world. Our own Rafugen ™ DBM Gel that Cellumed developed has obtained FDA approval in 2018, thus our biotechnology is also well acknowledged overseas. In addition to distributing allografts, it is leading tissue bank in Korea that has the technology to directly process and sterilize human tissues, and is managed by the Ministry of Food and Drug Safety (MFDS) every year to handle safe human tissues. In order to contribute to human health, Cellumed spares no investments in research and development, such as medical devices and biotechnology, and strives to provide the best products and services.


Since its establishment in 2004,
GENOSS strictly fulfills and complies with the international quality regulations, including KGMP, ISO 13485 and ISO 9001.
Furthermore, the CE mark on each product confirms its conformity with all of the legal requirements.
GEONSS always concentrates on our customers and patients with the very high levels of innovation and technical expertise,
providing a wide range of products categorized as 3d cage, peek cage, and Bone & Tissue.


Comprehensive Solution Rapidly Changing Spine Industry
In this rapidly changing healthcare industry, every stakeholder faces their unique challenges. Surgeons, hospitals, distributors, and even patients, all need to rethink where to hang their hats. Based on spine industry expertise that GS Medical has gained since its founding in 2011, we have become one of few companies that understand current market challenges and provide optimized solutions for every stakeholder. With our New Spine Standard, you’ll find the way to succeed in this changing healthcare industry.



Medtronic, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 84,000 people worldwide, serving physicians, hospitals and patients in more than 160 countries. The company is committed to transforming healthcare especially in the areas of Therapy Innovation; providing a spectrum of offerings aimed at improving both economic and patient outcomes, Globalization; Adapting our thinking to address healthcare access challenges in both developed and developing countries, and Economic Value; Thinking more holistically about the care continuum, and how we can lead the creation of value-based healthcare solutions.

Medtronic’s business consists of four groups; Cardiac & Vascular Group, Diabetes Group, Minimally Invasive Therapies Group and Restorative Therapies Group. The Cardiac & Vascular Group products include Implantable devices like pacemakers, ICDs to correct heart rhythm issues, drug-coated balloons to open blocked arteries and so on. Diabetes Group focuses on computerized insulin pumps, injection ports and mobile monitoring. Minimally Invasive Therapies Group offers solutions that enable earlier diagnosis, better treatment, faster complication-free recovery, and enhanced patient outcomes through less-invasive treatments. Restorative Therapies Group provides Implantable deep-brain stimulation systems, revascularization devices and other pain therapies.

Silver Sponsors


DePuy Synthes Spine is the second largest spine company in the world with one of the most comprehensive portfolios of spinal care solutions that address key areas including thoracolumbar, cervical, aging spine, interbody fusion, and MIS surgery. The company's leading solutions include EXPEDIUM VERSE® Spinal System to treat spinal conditions ranging from scoliosis to degenerative disc disease; the CONCORDE® Systems & SYNCAGE® Evolution System to treat the Lumbar spine; the VIPER 2 and VIPER 3D™ System for MISS; SYNAPSE™ System and the ZERO-P® Family of Implants to treat the cervical spine and finally, a suite of biomaterial solutions like DBX.


The sales of Hans Biomed Co. have grown around 25% for the last 5 years in a row, holding a stable financial position. In addition, we have 7 overseas subsidiaries and local branch offices around the world to expand business in the world. Starting R&D investment in new medical treatments and technology relate to regenerative medicine as well as tissue engineering, Hans Biomed has prepared itself for a new challenge for better health of humankind.


Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a global, integrated healthcare services and products company, providing customized solutions for hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide.
The company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home. Cardinal Health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. Backed by nearly 100 years of experience, with approximately 50,000 employees in 46 countries, Cardinal Health ranks among the top 25 on the Fortune 500.
Cardinal Health is more than a business, more than a partner, more than hard workers. It’s wings. Its unrivaled scale and focused approach leads to better solutions. The company’s strength flows from four areas of expertise: logistics, product, business and patient solutions. Cardinal Health welcomes new challenges, anticipates trends, and as Wings, brings support, speed, and mile-high vision to all customers.


inno.N has technology-focused business competitiveness in the fields of ETC Drugs, APIs, and Health & Beauty Care.
In 2019, inno.N launched the new medicine for gastroesophageal reflux disease, "K-CAB Tab.," was released as the 30th new drug in Korea. Furthermore, inno.N unrivaled in the basic IV fluids and anti-hangover drink markets.
It has more than 20 new drug and biopharmaceutical pipelines centered on digestion, oncology, liver, Auto immune, and infection, and recently established a future growth engine by entering the cell gene therapy business.
With the 'Heal the World For Better Life' mission, inno.N will develop innovative new drugs and become a global pharmaceutical company that customers can trust.

Bronze Sponsors


Established in 1945, Daewoong Pharmaceutical Co., Ltd. has the largest prescription drug sales in Korea and envisions itself to become a top 50 global healthcare company by 2020.
In addition to its product portfolio, which includes 15 blockbuster products, Daewoong has built strong core competency for new drug development and has cultivated a cooperative culture for collaboration with global partners.
In the future, Daewoong will expand its global business with its foreign branches and global partners and become a global healthcare group which contributes to improving the quality of life for people worldwide.

DK Medical Solutions CO., LTD.

The best healthcare company where professionals with passion and new values

DK established in 1986 is a healthcare provider that aims to provide excellent medical equipment and advanced medical technology to the medical industry to improve people's quality of life. DK distributes advanced medical technology to the market, contributing to medical development, as well as producing medical equipment.

DK contributes to the improvement of the national health and the development of the healthcare industry by providing innovate technologies and building close collaborations with customers. ​


Founded in 2003 by Edward J.W. Jang, Medyssey is privately owned and headquartered in Seoul, Korea.
The Company has a pioneering focus on bringing leading orthopaedic and neurosurgical spinal implants to market. Medyssey's technological advancement of spinal surgery has accelerated growth in Asia Pacific, the Americas, the EU and emerging international markets.
As a pioneer of motion preservation and dynamic stabilization, Medyssey has staked a position as a global leader with an innovative product portfolio, robust research and development pipeline, and a distribution footprint that now spans 17 countries covering six continents.
In the Company's quest to become a market leader, Medyssey is committed to generating, developing, and commercializing intellectual property that improve the quality of patients' lives while designed under the mantra of simple and reproducible.


Joimax®, the leading endoscopic spine company, offers complete solutions from deherniation/decompression and denervation to more complex procedures like stabilization and fusion. Additionally, Joimax® is always striving to advance the endoscopic world by continuously developing new products and technology like the award-winning electromagnetic navigation system, Intracs® em. Joimax® is also a big supporter of The Endoscopic Spine Academy, ESPINEA®, where they offer comprehensive educational programs for doctors at all levels in their endoscopic careers.


Since its establishment in 1968, SAMJIN Pharm. has strived to develop and research new drugs for the healthy life and fruitful future over a half century.

SAMJIN Pharmaceutical company, founded in 1968, is one of leading companies in Korea with competitive medical products such as Platless, Geworin, Neustatin-A, Bamedin and etc. R&D Center of Samjin Pharm is strengthening its global competitiveness by getting the outstanding pipeline such as oral preparation for dry eye syndrome and anti-cancer agents.

Editorial Office
Department of Neurosurgery, Yonsei University College of Medicine
50-1, Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-2228-2158  E-mail:
The Korean Spinal Neurosurgery Society
#407, Dong-A Villate 2nd Town, 350 Seocho-daero, Seocho-gu, Seoul 06631, Korea
Tel: +82-2-585-5455  Fax: +82-2-2-523-6812  E-mail:
Business License No.: 209-82-62443

Copyright © The Korean Spinal Neurosurgery Society.

Developed in M2PI

Close layer
prev next